Importantly for GLP-1 therapy, which often requires urgent titration (weight-loss drugs have fastest impacts initially), quicker approvals can improve adherence: patients are less likely to abandon treatment if they get started immediately
It is also important to be vigilant about symptoms that may indicate kidney stress during treatment, including: Reduced urine output or dark-coloured urine Swelling in the legs or ankles Persistent nausea, fatigue, or confusion Flank or lower back pain If any of these symptoms develop after starting a weight loss medication, you should stop the medication and seek medical advice promptly
Fragmented tracking obscures causation when dosing, side effects, menstrual changes, and cravings overlap, and clinicians often need organized, time-stamped data over 3 months to separate drug effects from adherence or baseline variability
They resemble normal flat melanocytic nevi or may even be confused with freckles or lentigines